Skip to main content

News Archive

News Archive - Susanne Clara Bard

Study: Popular GLP-1 Drug May Slow Down Biological Aging

A study by UC San Diego researchers and their colleagues has found that semaglutide slows down the accumulation of biological aging markers in the DNA of adults with HIV, pointing to the potential of GLP‑1 receptor agonists to help prevent age‑related diseases.

Machine Learning Personalizes Depression Treatment with the Help of Wearable Technology

UC San Diego researchers report substantial reductions in symptoms of depression by using machine learning to tailor behavioral interventions based on data participants collect about their own moods and daily habits.

UC San Diego Researchers Shine a Light on Peripheral Artery Disease

UC San Diego researchers find that a simple technology that measures blood volume changes coupled with machine learning can be used to screen for peripheral artery disease with a high degree of accuracy.

From Molecules to Meaning: A Search Engine for the Chemistry of Life

A new web tool called StructureMASST lets anyone search the world’s public metabolomics data by chemical structure.

Predicting Genetic Risk for Type 1 Diabetes Just Got More Accurate Thanks to UC San Diego Study

UC San Diego researchers have developed T1GRS, a machine‑learning model that accurately predicts genetic risk for Type 1 diabetes, paving the way for earlier diagnosis and more personalized treatment.

$13 Million CIRM Award to Fund Research on the Role of RNA Pollution in Neurodegenerative Diseases

UC San Diego has received a $13 Million grant from the California Institute for Regenerative Medicine (CIRM) to investigate how RNA pollution drives neurodegenerative diseases and to develop novel therapies that protect the aging brain.

First Large‑scale Survey Estimates that 2.8% of U.S. Population Used Psilocybin in the Past Year

An analysis of the first national survey of psilocybin use suggests that 2.8% of Americans over the age of 12 have used the drug in the past year, with implications for clinical practice.

To Thwart Pathogens, Researchers are Giving Beneficial Microbes What They Really Want

UC San Diego researchers have developed a new method that allows precise modification of any microbiome with prebiotics, helping beneficial organisms outcompete dangerous pathogens.

UC San Diego School of Medicine Ranked No. 4 Nationally for NIH Funding Among Public Institutions

The University of California San Diego School of Medicine ranked No. 4 among public institutions and No. 14 overall nationwide for NIH funding in 2025 as reported by the Blue Ridge Institute for Medical Research (BRIMR).

Understanding Substance Use Across the Full Spectrum of Sexual Identity

An analysis of the 2023 National Survey on Drug Use and Health reveals higher rates of substance use among all non‑heterosexual groups, including people who describe their sexual identity using non‑traditional terms or who are not sure of their sexual identity.

Search UC San Diego Today